Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Board Appointment

1 Feb 2005 12:00

Cello Group plc01 February 2005 1 February 2005 Cello Group plc Board Appointment The board of Cello Group plc ("Cello") announces the appointment of Mark Bentleyas Group Finance Director and Company Secretary. It is expected that he willjoin the board in late April, subject to existing contractual obligations. Mark Bentley (34) is currently Chief Operating Officer of Citigate Dewe RogersonLimited and Finance Director of Citigate SMARTS Group, part of Incepta Groupplc. Prior to this, he was Financial Projects Manager at Hodder Headline plc.He qualified as a chartered accountant with PriceWaterhouseCoopers in 1996. Commenting on his appointment, Kevin Steeds, Chairman of Cello said: "We lookforward to welcoming Mark to the Group. He combines the traditional professionalfinancial background with some excellent operational experience in the marketingservices industry. I am sure he will play a key role in the future growth plansof Cello" - ENDS - Enquiries: Kevin Steeds - Chairman - Cello Group plc Tel: 020 7324 6120 Adrian Duffield - College Hill Tel: 020 7457 2020 Notes to Editors:- (www.cellogroup.co.uk) Cello Group plc, a newly incorporated marketing services group which listed onAIM in November 2004 and comprises four businesses which operate in threedifferent niches of the marketing services sector: - healthcare market research,direct and database marketing and brand advertising. Each share significantorganic and acquisitive growth potential; blue chip client lists and a longtrack record of client loyalty; experienced, high quality management teams;profitability; and potential for enhancing gross margins. Market research • Insight is a specialist healthcare market research business employing some 75 people and has offices in central London and New Jersey. Its clients include GlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals, NovoNordisk, Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp and Dohme. Brand advertising • Leith is the largest and most successful advertising agency in Scotland employing 60 people. The agency has been voted Scottish Agency of the Year for the last five years. Leith opened a London office in 2000 which has grown from a start-up to 25 people. Leith's major clients are Standard Life, Irn Bru, Scottish Executive, Standard Life Bank, Hotpoint, Goodfellas Pizza and Carling. Direct marketing and database management • Target, based in Cheltenham, is the UK's leading direct marketing consultancy specialising in the "not-for-profit" and charity sector. The agency works for five of the top 20 charities in the UK and employs some 80 people. Target has also expanded its offer to the "grey market", working for clients such as The National Trust, Saga Holidays and Which? Limited. Target's subsidiary, Talking Numbers is a leading database management and analytics company. • Navigator Responsive Advertising is Scotland's number one direct marketing company employing 40 people and provides responsive communication solutions for a wide range of clients. Areas of expertise include strategic planning, database marketing, customer relationship management and creative solutions - utilising a wide range of media that includes direct mail, press, outdoor, radio, DRTV and electronic media. Navigator was a winner of eight industry awards in 2004. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jun 20181:24 pmRNSBlock listing Interim Review
29th May 20183:45 pmRNSDirector/PDMR Dealings and Total Voting Rights
9th May 20181:14 pmRNSResult of AGM
9th May 20187:00 amRNSAGM Statement
30th Apr 20182:58 pmRNSTotal Voting Rights
26th Apr 20189:45 amRNSChange of Name
25th Apr 20184:45 pmRNSChange of Name update
23rd Apr 201810:28 amRNSChange of name to Cello Health Group plc
16th Apr 20189:30 amRNSAnnual Report and Notice of AGM
22nd Mar 20187:00 amRNSFinal Results
27th Feb 20183:38 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSPre Close Trading Statement
23rd Nov 20173:54 pmRNSHolding(s) in Company
31st Oct 201711:16 amRNSTotal Voting Rights
26th Oct 20172:37 pmRNSDirector/PDMR Shareholding
29th Sep 20173:43 pmRNSGrant of Options
27th Sep 20174:59 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:05 pmRNSDirector/PDMR Shareholding
20th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 201711:52 amRNSAdditional Block Listing of Ordinary Shares
20th Sep 20177:00 amRNSInterim Results
31st Aug 20173:19 pmRNSTotal Voting Rights
31st Jul 20173:06 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSPre Close Trading Statement
18th Jul 20177:00 amRNSAcquisition of Advantage Healthcare Inc
30th Jun 201712:31 pmRNSTotal Voting Rights
23rd Jun 201712:23 pmRNSHolding(s) in Company
14th Jun 201711:33 amRNSDirector/PDMR Shareholding
31st May 201710:27 amRNSTotal Voting Rights
18th May 20172:13 pmRNSHolding(s) in Company
10th May 20175:18 pmRNSHolding(s) in Company
9th May 20172:55 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Statement
2nd May 20173:15 pmRNSIssue of Equity
13th Apr 20172:40 pmRNSAnnual Report and notice of Annual General Meeting
4th Apr 20175:44 pmRNSBlock listing Interim Review
31st Mar 201710:43 amRNSTotal Voting Rights
28th Mar 20173:03 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSPreliminary Results
21st Feb 20171:30 pmRNSHolding(s) in Company
20th Feb 20173:19 pmRNSHolding(s) in Company
20th Feb 20179:29 amRNSTotal Voting Rights
17th Feb 201710:40 amRNSResult of General Meeting
1st Feb 20177:00 amRNSPlacing & Acquisition of Defined Health
19th Jan 20177:00 amRNSPre close trading statement
31st Oct 20163:58 pmRNSTotal Voting Rights
28th Oct 201611:37 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSDirectorate Change
5th Oct 20164:32 pmRNSDirector/PDMR Shareholding
23rd Sep 20165:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.